In regulatory news:

The FDA announced that it has warned four additional online networks, operating a total of 21 websites, for illegally marketing misbranded opioid medications. The warning letters, issued by the FDA to each of the networks, state that they must immediately stop illegally selling these products to American consumers. The effort “builds on previous actions against the illegal online sale of opioids, for a total of 13 warning letters to more than 70 websites just this summer,” said FDA Commissioner Scott Gottlieb, M.D. in a press release yesterday.

Read more here.

Leave a Comment

Your email address will not be published. Required fields are marked *